NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) is a premixed insulin analog indicated to improve glycemic control in patients with diabetes mellitus.
NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension)
Search for Letters
Find documents for this product by entering your search terms in the box below.
Have a Question?
Request information directly from the Novo Nordisk
Medical Information department.
Have a Question?
All fields required.